The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour
Open accessAbstract
BACKGROUND: The routine prophylactic administration of an uterotonic agent is an integral part of active management of the third stage of labour, helping to prevent postpartum haemorrhage (PPH). The two most widely used uterotonic agents are: ergometrine-oxytocin (Syntometrine) (a combination of oxytocin 5 international units (iu) and ergometrine 0.5 mg) and oxytocin (Syntocinon). OBJECTIVES: To compare the effects of ergometrine-oxytocin with oxytocin in reducing the risk of PPH (blood loss of at least 500 ml) and other maternal and neonatal outcomes. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group trials register (May 2003). SELECTION CRITERIA: Randomised trials comparing ergometrine-oxytocin use with oxytocin use in women having the third stage of labour managed actively. DATA COLLECTION AND ANALYSIS: We independently assessed trial eligibility and quality and extracted data. We contacted study authors for additional information. MAIN RESULTS: Six trials were included (9332 women). Compared with oxytocin, ergometrine-oxytocin was associated with a small reduction in the risk of PPH using the definition of PPH of blood loss of at least 500 ml (odds ratio 0.82, 95% confidence interval 0.71 to 0.95). This advantage was found for both a dose of 5 iu oxytocin and a dose of 10 iu oxytocin, but was greater for the lower dose. There was no difference detected between the groups using either 5 or 10 iu for the stricter definition of PPH of blood loss at least 1000 ml. Adverse effects of vomiting, nausea and hypertension were more likely to be associated with the use of ergometrine-oxytocin. When heterogeneity between trials was taken into account there were no statistically significant differences found for the other maternal or neonatal outcomes. REVIEWER'S CONCLUSIONS: The use of ergometrine-oxytocin as part of the routine active management of the third stage of labour appears to be associated with a small but statistically significant reduction in the risk of PPH when compared to oxytocin for blood loss of 500 ml or more. No statistically significant difference was observed between the groups for blood loss of 1000 ml or more. A statistically significant difference was observed in the presence of maternal side-effects, including elevation of diastolic blood pressure, vomiting and nausea, associated with ergometrine-oxytocin use compared to oxytocin use. Thus, the advantage of a reduction in the risk of PPH, between 500 and 1000 ml blood loss, needs to be weighed against the adverse side-effects associated with the use of ergometrine-oxytocin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes
McDonald, S. J., Middleton, P., Dowswell, T., & Morris, P. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004074.pub3 · Cited by 890
Self-citation
Cited by
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Renfrew, M. J., McFadden, A., Bastos, M. H., Campbell, J., Channon, A. A., Cheung, N. F., Silva, D. R. A. D., Downe, S., Kennedy, H. P., Malata, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60789-3 · Cited by 1,297
Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes
McDonald, S. J., Middleton, P., Dowswell, T., & Morris, P. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004074.pub3 · Cited by 890
Self-citationPrevention and Management of Postpartum Haemorrhage: Green‐top Guideline No. 52
(2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14178 · Cited by 756
Active versus expectant management in the third stage of labour
Prendiville, W. J., Elbourne, D., & McDonald, S. J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000007 · Cited by 496
Self-citationRetracted
Metadata
- Authors
- McDonald, S. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2004-01-26
- Volume
- 2018
- Issue
- 2
- Pages
- CD000201-CD000201
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1749719431
- Cited by
- 201
- References
- 1
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. https://app.cochat.ai/papers/10.1002/14651858.cd000201.pub2
- The paper
- McDonald, S. J. (2004). Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000201.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.